
FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell ...
FDA News Release Agency determines the safety and effectiveness of these immunotherapies can be assured without a REMS For Immediate Release: June 27, 2025 The U.S. Food and Drug Administration announced today that it has eliminated the Risk Evaluation and …